CLOVIS ONCOLOGY INC's ticker is and the CUSIP is 189464AB6.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $998,000,000 | -51.1% | 1,000,000 | -53.9% | 0.01% | -69.0% |
Q1 2021 | $2,040,000,000 | +2.2% | 2,170,000 | 0.0% | 0.03% | -29.3% |
Q4 2020 | $1,996,000,000 | +1.1% | 2,170,000 | 0.0% | 0.04% | -18.0% |
Q3 2020 | $1,975,000,000 | +1.1% | 2,170,000 | 0.0% | 0.05% | +16.3% |
Q2 2020 | $1,953,000,000 | +118.2% | 2,170,000 | +117.0% | 0.04% | +138.9% |
Q1 2020 | $895,000,000 | -88.8% | 1,000,000 | -91.4% | 0.02% | -87.7% |
Q1 2016 | $7,960,000,000 | -6.8% | 11,625,000 | +16.2% | 0.15% | +1.4% |
Q4 2015 | $8,540,000,000 | – | 10,000,000 | – | 0.14% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
LINDEN ADVISORS LP | 69,346,000 | $107,321,000 | 3.81% |
PFM Health Sciences, LP | 34,710,000 | $53,670,000 | 1.06% |
Partner Investment Management, L.P. | 556,000 | $860,000 | 0.82% |
Myriad Asset Management Ltd. | 5,000,000 | $7,731,000 | 0.75% |
SYMPHONY ASSET MANAGEMENT LLC | 4,000,000 | $6,185,000 | 0.69% |
CAPSTONE INVESTMENT ADVISORS, LLC | 9,074,000 | $14,030,000 | 0.49% |
CSS LLC/IL | 5,251,000 | $8,112,000 | 0.40% |
SSI INVESTMENT MANAGEMENT LLC | 2,813,000 | $4,333,000 | 0.37% |
ADVENT CAPITAL MANAGEMENT /DE/ | 7,131,000 | $11,056,000 | 0.21% |
D. E. Shaw & Co., Inc. | 27,750,000 | $42,835,000 | 0.07% |